Christopher D. Galloway

Insider Reports History

Entity
Individual
Location
1317 Carlton Avenue, Suite 200, Charlottesville, VA
Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher D. Galloway:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Diffusion Pharmaceuticals Inc. Chief Medical Officer Stock Option (Right to Buy) 306K Jan 27, 2022 Direct

Insider Reports Filed by Christopher D. Galloway

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DFFN Diffusion Pharmaceuticals Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 Chief Medical Officer